C4X Discovery was formed as a spin-out from the University of Manchester in 2008 and is focused on the optimisation of drug discovery and design. It uses its NMR-based technology to accurately solve the bioactive three-dimensional structures of molecules independently of techniques such as X-ray crystallography and computational chemistry. As well as working in partnership with the pharmaceutical industry, C4X Discovery is applying its technology to high-value therapeutic targets to generate proprietary drug candidates and intellectual property.